Compare Summit Therapeutics Inc (SMMT) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Summit Therapeutics Inc vs TransMedics Group Inc — how do they compare? Summit Therapeutics Inc trades at $14.57 (market cap $10.48B), while TransMedics Group Inc trades at $74.3 (market cap $2.54B). The key difference: Summit Therapeutics Inc is far larger — about 4.1× TransMedics Group Inc's market cap. Which is the better fit depends on your goals.
| SMMT | TMDX | |
|---|---|---|
Market Cap | $10.48B | $2.54B |
Sector | Health | Technology |
52-Week High | $29.32 | $150.42 |
52-Week Low | $13.05 | $61.99 |
Enterprise Value | $9.90B | $2.94B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
